Company logo

SAVA - Cassava Sciences, Inc.

NASDAQ -> Healthcare -> Biotechnology
Austin, United States
Type: Equity

SAVA price evolution
SAVA
(in millions $) 30 Jun 2022 31 Mar 2022 31 Dec 2021 30 Sep 2021
Current assets
Cash $197.23 $209.69 $233.44 $241.52
Short term investments
Net receivables
Inventory
Total current assets $204.2 $222.2 $244.48 $251.91
Long term investments
Property, plant & equipment $22.32 $21.05 $20.83 $20.93
Goodwill & intangible assets $0.86 $0.94 $1.07 $1.21
Total noncurrent assets $23.18 $21.99 $22.3 $22.33
Total investments
Total assets $227.38 $244.19 $266.78 $274.25
Current liabilities
Accounts payable $4.76 $3.33 $7.13 $2.35
Deferred revenue
Short long term debt $0.1 $0.1 $0.1 $0.1
Total current liabilities $8.72 $6.79 $12.53 $6.33
Long term debt $0.09 $0.11 $0.14 $0.16
Total noncurrent liabilities $0.29 $0.31 $0.33 $0.36
Total debt $0.19 $0.21 $0.24 $0.26
Total liabilities $9.01 $7.1 $12.87 $6.68
Shareholders' equity
Retained earnings -$244.16 -$224.83 -$207.31 -$193.13
Other shareholder equity
Total shareholder equity $218.37 $237.09 $253.91 $267.56
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Current assets
Cash $233.44 $93.51 $23.08 $19.81
Short term investments
Net receivables
Inventory
Total current assets $244.48 $93.99 $23.35 $20.04
Long term investments
Property, plant & equipment $20.83 $0.31 $0.14 $0.09
Goodwill & intangible assets $1.07
Total noncurrent assets $22.3 $0.31 $0.14 $0.1
Total investments
Total assets $266.78 $94.3 $23.49 $20.14
Current liabilities
Accounts payable $7.13 $0.91 $0.45 $0.29
Deferred revenue
Short long term debt $0.1 $0.06 $0.09
Total current liabilities $12.53 $1.86 $1.39 $0.51
Long term debt $0.14 $0.23
Total noncurrent liabilities $0.33 $0.23
Total debt $0.24 $0.29 $0.09
Total liabilities $12.87 $2.1 $1.39 $0.51
Shareholders' equity
Retained earnings -$207.31 -$174.92 -$168.59 -$163.96
Other shareholder equity
Total shareholder equity $253.91 $92.2 $22.1 $19.63
(in millions $) 30 Jun 2022 31 Mar 2022 31 Dec 2021 30 Oct 2021
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $16.95 $14.91 $10.34
Selling, general & administrative $2.97 $2.92 $4.1
Total operating expenses $19.92 $17.82 $14.44
Operating income -$19.92 -$17.82 -$14.44
Income from continuing operations
EBIT -$19.33 -$17.53 -$14.17
Income tax expense
Interest expense
Net income
Net income -$19.33 -$17.53 -$14.17
Income (for common shares) -$19.33 -$17.53 -$14.17
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $24.81 $3.05 $1.57 $2.97
Selling, general & administrative $8.05 $3.74 $3.39 $3.69
Total operating expenses $32.87 $6.45 $4.96 $6.66
Operating income -$32.87 -$6.45 -$4.96 -$6.66
Income from continuing operations
EBIT -$32.38 -$6.33 -$4.63 -$6.56
Income tax expense
Interest expense
Net income
Net income -$32.38 -$6.33 -$4.63 -$6.56
Income (for common shares) -$32.38 -$6.33 -$4.63 -$6.56
(in millions $) 30 Jun 2022 31 Mar 2022 31 Dec 2021 30 Sep 2021
Net income -$19.33 -$17.53 -$14.17 -$9.56
Operating activities
Depreciation $0.3 $0.31 $0.31 $0.21
Business acquisitions & disposals
Stock-based compensation $0.48 $0.49 $0.52 $0.57
Total cash flows from operations -$11.11 -$23.53 -$7.99 -$14.76
Investing activities
Capital expenditures -$1.47 -$0.42 -$0.1 -$22.04
Investments
Total cash flows from investing -$1.47 -$0.42 -$0.1 -$22.04
Financing activities
Dividends paid
Sale and purchase of stock $0.12 $0.21 $0.07
Net borrowings
Total cash flows from financing $0.12 $0.21 $0.07
Effect of exchange rate
Change in cash and equivalents -$12.46 -$23.74 -$8.09 -$36.73
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Net income -$32.38 -$6.33 -$4.63 -$6.56
Operating activities
Depreciation $0.53 $0.02 $0.06 $0.07
Business acquisitions & disposals
Stock-based compensation $1.76 $0.99 $1.3 $2.39
Total cash flows from operations -$30.2 -$5.38 -$2.51 -$4.77
Investing activities
Capital expenditures -$22.21 $0.36 -$0.02
Investments
Total cash flows from investing -$22.21 $0.36 -$0.02
Financing activities
Dividends paid
Sale and purchase of stock $192.34 $75.45 $5.87 $14.1
Net borrowings
Total cash flows from financing $192.34 $75.45 $5.81 $14.1
Effect of exchange rate
Change in cash and equivalents $139.93 $70.42 $3.27 $9.33
Fundamentals
Market cap $1.64B
Enterprise value $1.45B
Shares outstanding 40.10M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 7.52
Book/Share 5.45
Cash/Share 4.92
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 0.05
Net debt/EBITDA N/A
Current ratio 23.41
Quick ratio 23.41